Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch | FDA

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch | FDA

Comments

Popular posts from this blog

Fresh Express Recalls Romaine-based Salads with Use-by Dates of May 13-16th Due to Possible Health Risk

Watershed Creation

Obama's Political Gesture Is Good Sign -- But Not Close To What Is Necessary To Secure Borders